Literature DB >> 15126609

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

José Palacios, Emiliano Honrado, Ana Osorio, Orland Diez, Carmen Rivas, Javier Benítez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15126609     DOI： 10.1093/jnci/djh115

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  The pathology of hereditary breast cancer.

Authors:  Emiliano Honrado; Javier Benítez; José Palacios
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

2.  Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

Authors:  Socorro María Rodríguez-Pinilla; David Sarrió; Emiliano Honrado; Gema Moreno-Bueno; David Hardisson; Francisco Calero; Javier Benítez; José Palacios
Journal:  J Clin Pathol       Date:  2006-11-14       Impact factor: 3.411

Review 3.  The complex genetic landscape of familial breast cancer.

Authors:  Lorenzo Melchor; Javier Benítez
Journal:  Hum Genet       Date:  2013-04-05       Impact factor: 4.132

4.  Familial breast/ovarian cancer and BRCA1/2 genetic screening: the role of immunohistochemistry as an additional method in the selection of patients.

Authors:  Fátima H Vaz; Patrícia M Machado; Rita D Brandão; Cátia T Laranjeira; Joana S Eugénio; Aires H Fernandes; Saudade P André
Journal:  J Histochem Cytochem       Date:  2007-07-11       Impact factor: 2.479

5.  C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Int J Cell Biol       Date:  2013-05-20

6.  Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.

Authors:  Hannaleena Eerola; Mira Heinonen; Päivi Heikkilä; Outi Kilpivaara; Anitta Tamminen; Kristiina Aittomäki; Carl Blomqvist; Ari Ristimäki; Heli Nevanlinna
Journal:  Breast Cancer Res       Date:  2008-02-14       Impact factor: 6.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.